Lipoprotéine HDL And NotK. M. A. Welch

List of bibliographic references

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
000227	Bruno Verges [France] ; Martin Adiels [Suède] ; Jan Boren [Suède] ; Peter Hugh Barrett [Australie] ; Gerald F. Watts [Australie] ; Dick Chan [Australie] ; Laurence Duvillard [France] ; Sanni Söderlund [Finlande] ; Niina Matikainen [Finlande] ; Juhani Kahri [Finlande] ; Isabelle Robin [France] ; Marja-Riitta Taskinen [Finlande]	Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study
000533	Robert S. Rosenson [États-Unis] ; H. Bryan Jr Brewer [États-Unis] ; Benjamin Ansell [États-Unis] ; Philip Barter [Australie] ; M. John Chapman [France] ; Jay W. Heinecke [États-Unis] ; Anatol Kontush [France] ; Alan R. Tall [États-Unis] ; Nancy R. Webb [États-Unis]	Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges
000934	Bronwyn A. Kingwell [Australie] ; M. John Chapman [France]	Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease
001520	M. John Chapman [France] ; Henry N. Ginsberg [États-Unis] ; Pierre Amarenco [France] ; Felicita Andreotti [Italie] ; Jan Boren [Suède] ; Alberico L. Catapano [Italie] ; Olivier S. Descamps [Belgique] ; Edward Fisher [États-Unis] ; Petri T. Kovanen [Finlande] ; Jan Albert Kuivenhoven [Pays-Bas] ; Philippe Lesnik [France] ; Luis Masana [Espagne] ; Borge G. Nordestgaard [Danemark] ; Kausik K. Ray [Royaume-Uni] ; Zeljko Reiner [Croatie] ; Marja-Riitta Taskinen [Finlande] ; Lale Tokgözoglu [Turquie] ; Anne Tybjaerg-Hansen [Danemark] ; Gerald F. Watts [Australie]	Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
001789	M. John Chapman [France]	Pitavastatin: Novel effects on lipid parameters
001931	Fatiha Tabet [Australie] ; Gilles Lambert [Australie, France] ; Luisa F. Cuesta Torres [Australie] ; LIMING HOU [Australie] ; Irene Sotirchos [Australie] ; Rhian M. Touyz [Canada] ; Alicia J. Jenkins [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie]	Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages
001F69	Fatiha Tabet [Australie] ; Alan T. Remaley [États-Unis] ; Aude I. Segaliny [Australie] ; Jonathan Millet [Australie] ; LING YAN [Australie] ; Shirley Nakhla [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Gilles Lambert [France]	The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro
002203	Estelle Nobecourt [Australie] ; Fatiha Tabet [Australie] ; Gilles Lambert [Australie] ; Rajesh Puranik [Australie] ; SHISAN BAO [Australie] ; LING YAN [Australie] ; Michael J. Davies [Australie] ; Bronwyn E. Brown [Australie] ; Alicia J. Jenkins [France] ; Gregory J. Dusting [Australie] ; David J. Bonnet [Australie] ; Linda K. Curtiss [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [États-Unis]	Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I
002A97	Amal Zerrad-Saadi [France] ; Patrice Therond [France] ; Sandrine Chantepie [France] ; Martine Couturier [France] ; Kerry-Anne Rye [Australie] ; M. John Chapman [France] ; Anatol Kontush [France]	HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024